MedXLink, Corp., ("the Company") was organized in May 1983 in the State of New York under the name "National Thoroughbred Corporation." Subsequently, the name was changed to "NTC Holdings, Inc.". Although originally formed to engage in purchasing, breeding and selling Thoroughbred horses, the company's management anticipates merging with an as yet unidentified on-going business in the future.

The board of directors feel that the Company does not meet the criteria of a development stage company (as defined in SFAS 7 " Accounting and Reporting by Development Stage Enterprises ") primarily because it is not currently producing or marketing a product or service. However, the Company is currently seeking a business opportunity to merge with or acquire, but to date has not located any such business opportunities.

In seeking a business opportunity to merge with or acquire, management is reviewing various business plans. Management has not limited their review of plans or exploration of acquisitions to any particular industry or service sector. Management has not yet identified a business to complete such a transaction with and the Company has not entered into any binding agreements for an acquisition or merger. There is no assurance that the Company will be successful in finding any business opportunity to merge with or acquire.

On July 5, 2002 Articles of Merger were filed with the state of Nevada, merging NTC Holdings, Inc. a New York corporation into Medeport, Inc. a Nevada Corporation for the purpose of changing domicile. On July 12, 2002 the name was changed from Medeport, Inc. to MedXLink Corp. The shareholders agreed to eliminate the Class A Preferred stock of 1 share ($.001 par value) and the Class B Preferred stock of 1,000,000 shares ($.001 par value). Both classes of preferred stock had no shares issued and outstanding.